ASX
Prescient Therapeutics Limited
PTX:ASX•Healthcare
Sensitive ASX Announcement
Phase 1b/2 Ovarian Trial Commences 2nd Dose Escalation
Published: 08/12/16, 01:16pm (AEST)•2 pages